Foresite Labs, LLC
CIK: 0002027905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALUMIS INC.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Apr 1, 2026ALMS
ALUMIS INC.
Other(J)Indirect1.2M shares- - Apr 1, 2026ALMS
ALUMIS INC.
Other(J)Indirect1.1M shares- - Apr 1, 2026ALMS
ALUMIS INC.
Other(J)Indirect1.1M shares- - Apr 1, 2026ALMS
ALUMIS INC.
Other(J)Indirect680.5K shares- - Jan 8, 2026ALMS
ALUMIS INC.
Purchase(P)Indirect117.6K shares at avg. $17.00$2.0M - Jan 8, 2026ALMS
ALUMIS INC.
Purchase(P)Indirect294.1K shares at avg. $17.00$5.0M - Nov 21, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect72.2K shares at avg. $7.38$533K - Nov 19, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect190.5K shares at avg. $6.56$1.2M - Nov 18, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect117.4K shares at avg. $6.19$727K - Nov 17, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect50K shares at avg. $5.60$280K - Nov 17, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect150K shares at avg. $5.59$839K - May 6, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect20K shares at avg. $4.34$87K - May 2, 2025ALMS
ALUMIS INC.
Purchase(P)Indirect25K shares at avg. $4.62$116K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | ALMS ALUMIS INC. | Other(J) | 1,176,470 | - | $0 | Indirect |
| Apr 1, 2026 | ALMS ALUMIS INC. | Other(J) | 1,123,337 | - | $0 | Indirect |
| Apr 1, 2026 | ALMS ALUMIS INC. | Other(J) | 1,123,337 | - | $0 | Indirect |
| Apr 1, 2026 | ALMS ALUMIS INC. | Other(J) | 680,486 | - | $0 | Indirect |
| Jan 8, 2026 | ALMS ALUMIS INC. | Purchase(P) | 117,647 | $17.00 | $1,999,999 | Indirect |
| Jan 8, 2026 | ALMS ALUMIS INC. | Purchase(P) | 294,117 | $17.00 | $4,999,989 | Indirect |
| Nov 21, 2025 | ALMS ALUMIS INC. | Purchase(P) | 72,212 | $7.38 | $532,925 | Indirect |
| Nov 19, 2025 | ALMS ALUMIS INC. | Purchase(P) | 190,500 | $6.56 | $1,249,680 | Indirect |
| Nov 18, 2025 | ALMS ALUMIS INC. | Purchase(P) | 117,374 | $6.19 | $726,545 | Indirect |
| Nov 17, 2025 | ALMS ALUMIS INC. | Purchase(P) | 50,000 | $5.60 | $280,000 | Indirect |
| Nov 17, 2025 | ALMS ALUMIS INC. | Purchase(P) | 150,000 | $5.59 | $838,500 | Indirect |
| May 6, 2025 | ALMS ALUMIS INC. | Purchase(P) | 20,000 | $4.34 | $86,800 | Indirect |
| May 2, 2025 | ALMS ALUMIS INC. | Purchase(P) | 25,000 | $4.62 | $115,500 | Indirect |
1-13 of 13 transactions
About Foresite Labs, LLC
Foresite Labs, LLC (SEC CIK 0002027905) files insider reports with the SEC as 10% Owner of ALUMIS INC. (ALMS).
Signal8 holds 5 ownership filings by Foresite Labs, LLC, all Form 4s, filed between May 6, 2025 and Apr 3, 2026. Those filings report 13 transactions, from May 2, 2025 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Foresite Labs, LLC's filings is in SAN FRANCISCO, CA.
Recent filings by Foresite Labs, LLC
- Apr 1, 2026: Other transactions of ALMS shares (4 lines, Form 4, code J).
- Jan 8, 2026: Open-market purchases of ALMS shares (2 lines, Form 4, code P).
- Nov 21, 2025: Open-market purchase of ALMS shares (Form 4, code P).
- Nov 19, 2025: Open-market purchase of ALMS shares (Form 4, code P).
- Nov 18, 2025: Open-market purchase of ALMS shares (Form 4, code P).
Other insiders filing for ALUMIS INC. (ALMS)
- AKKARAJU SRINIVAS, Director
- Schroer John R., Chief Financial Officer
- Pangali Sanam, Chief Legal Officer
- Hardiman Roy C., Chief Business & Strategy Ofcr
- Goldstein David M, Chief Scientific Officer
- Drappa Jorn, Chief Medical Officer